|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/55 | |
| A61K 31/00 | |||
| A61K 9/00 | |||
| A61K 9/14 | |||
| A61P 25/28 | |||
| A61K 9/107 |
| (11) | Patento numeris | 3417862 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 18186075.0 |
| Europos patento paraiškos padavimo data | 2013-07-29 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-12-26 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-05-05 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 201261676348 P | 2012-07-27 | US | |
| 12178187 | 2012-07-27 | EP |
| (72) |
Maelicke, Alfred, DE
|
| (73) |
Neurodyn Life Sciences Inc.,
Suite 508 NRC-INH 550 University Ave, Charlottetown C1A 4P3,
CA
|
| (54) | ENHANCED BRAIN BIOAVAILABILITY OF GALANTAMINE BY SELECTED FORMULATIONS AND TRANSMUCOSAL ADMINISTRATION OF LIPOPHILIC PRODRUGS |
| ENHANCED BRAIN BIOAVAILABILITY OF GALANTAMINE BY SELECTED FORMULATIONS AND TRANSMUCOSAL ADMINISTRATION OF LIPOPHILIC PRODRUGS |